Aethlon Medical announces $3.3 million private placement and warrant inducement.
On December 5, 2025, in San Diego, Aethlon Medical, Inc. (Nasdaq: AEMD), a company specializing in medical therapeutics for cancer and infectious diseases, disclosed entering into a securities purchase agreement. The company is focused on developing innovative products for these critical areas.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments